Fitness app program for heart recovery after aortic valve replacement

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults recovering from transcatheter aortic valve replacement (TAVR), a heart valve procedure done through a tube, who can be referred to cardiac rehabilitation (a heart exercise and recovery program).

Age

18 years and older

Sex

All sexes

Disease stage

Recovering from TAVR for aortic valve disease. The UCHealth Structural Heart & Valve Clinic team must find you fit to be referred to cardiac rehabilitation.

Earlier treatment

Must have had transcatheter aortic valve replacement (TAVR).

Main reasons for not taking part

• The UCHealth Structural Heart and Valve Clinic team decides cardiac rehabilitation referral is not right for the person
• Not living in the community (for example, living in a care facility)
• Not living in the United States
• Cannot speak and understand English
• Cannot stand, even with a walking aid, or cannot see and hear content on the Peloton App

The registry criteria, word for word

What the trial wants to find out

This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health using wearable devices and a digital engagement platform. A total of 200 patients will be recruited from the UCHealth Structural Heart and Valve Clinic and randomized to either CardioHeartConnect or CardioHeartEd. Participants will be assessed at baseline, 8 weeks, and 12 months using surveys, smartwatch data, and electronic health records.

The 2 groups in the trial

• CardioHeartConnect (CHC, Peloton Modules)Treatment being tested

  Participants will receive access to an eight-week series of pre-set, clinically reviewed Peloton exercise modules delivered via the Ortus-iHealth platform. They will also receive a smartwatch designed to monitor physical activity and support engagement in cardiac rehabilitation after Transcatheter Aortic Valve Replacement (TAVR).

  Treatment: CardioHeartConnect

• CardioHeartEd (CHE, Informational Materials)Existing treatment, for comparison

  Participants will receive access to an eight-week series of cardiac rehabilitation-related educational materials developed by the American College of Cardiology, delivered through the Ortus-iHealth platform. Participants in this arm will also receive a smartwatch to parallel the intervention group and support activity tracking.

  Treatment: CardioHeartEd